Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of type 2 diabetes
Details for Australian Patent Application No. 2005229416 (hide)
International Classifications
Event Publications
5 October 2006 PCT application entered the National Phase
PCT publication WO2005/095418 Priority application(s): WO2005/095418
26 March 2009 Application Accepted
Published as AU-B-2005229416
23 July 2009 Standard Patent Sealed
25 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005229417-Plan nutrient based on o,p-ethylene(bis)hydroxyphenyl glycines
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser